Simsen Diagnostics is a company that provides ultrasensitive sequencing technologies to improve healthcare and introduce novel applications. They are a partner in Sweden’s innovation agency (VINNOVA) funded project “Ultrasensitive analysis for improved healthcare and forensics”. One of their products is Simsen Personal™, which is a highly sensitive and personalized molecular residual disease assay (MRD) using circulating tumor DNA (ctDNA), custom designed for each patient to help identify relapse earlier than standard-of-care tools.
Founded date: 2020
Investors 2
| Date | Name | Website |
| - | BioVenture... | azbioventu... |
| - | GU Venture... | guventures... |
Mentions in press and media 1
| Date | Title | Description |
| 14.03.2023 | Neogap and Simsen Diagnostics enter collaboration to improve personalised cancer diagnostics | Neogap and Simsen Diagnostics enter collaboration to improve personalised cancer diagnostics Tue, Mar 14, 2023 07:30 CET Report this content The biotechnology company Neogap and the cancer diagnostics company Simsen Diagnostics have initiat... |